Subscribe To

Price Alert Latest News Economic Calendar News

AMRN / Amarin Shareholders Invited to Webcast with Board and Management Team

-- Board and Management Team to Answer Shareholder Questions -- DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that members of its Board of Directors and management team will host a live webcast on Tuesday, February 14, 2023, from 8:00 a.m. - 9:00 a.m. ET. The webcast will be a question-and-answer session where the Company will answer some of the most common shareholder questions focused on Amarin's strategy and what the refreshed Board and management team are doing to drive operational and financial improvements and enhance value for all shareholders. Read More

Demo Live Account See Partner Details

Content Topics

Amarin

Shareholders

Invited

Webcast

With

Board

Management

Stock

AMRN

Posted: Feb 13 2023, 08:00

Author Name: GlobeNewsWire

AMRN News

By Zacks Investment Research
November 1, 2023

Amarin (AMRN) Q3 Earnings and Revenues Surpass Estimates

Amarin's (AMRN) third-quarter 2023 earnings and revenues beat estimates. Vascepa sales in the United States decline year over year.

By Seeking Alpha
September 26, 2023

Amarin Corporation plc (AMRN) Cantor Fitzgerald Annual Global Healthcare Conference (Transcript)

Amarin Corporation plc (NASDAQ:AMRN ) Cantor Fitzgerald Annual Global Healthcare Conference September 26, 2023 9:55 AM ET CompanyParticipants Patrick

By PennyStocks
August 17, 2023

10 Top Penny Stocks To Buy According To Insiders In August

Engaging in the world of low-cost stocks often referred to as penny stocks, is appealing to those looking to capitalize on the potential upsides of th

By Zacks Investment Research
July 19, 2023

Amarin (AMRN) Dips 16% on Layoff Plan & Preliminary Sales Miss

Amarin (AMRN) decides to initiate a restructuring plan to maximize cash flow opportunities in the United States. It also reports preliminary product r

By Seeking Alpha
June 26, 2023

Amarin: New Management, But No Radical Changes To Strategy, Or Outlook

Amarin recently acquired a completely revamped management. There seems to be no radical shift in strategy, however. Therefore, there is no radical cha

By Seeking Alpha
June 13, 2023

Amarin Corporation plc (AMRN) Presents at Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)

Start Time: 17:40 January 1, 0000 6:14 PM ET Amarin Corporation plc (NASDAQ:AMRN ) Goldman Sachs 44th Annual Global Healthcare Conference June 12, 202

By Zacks Investment Research
May 3, 2023

Amarin's (AMRN) Q1 Earnings Top, Vascepa Sales Fall

Amarin's (AMRN) first-quarter 2023 earnings and revenues beat estimates. Vascepa sales decline.

By Seeking Alpha
April 16, 2023

Amarin: Sarissa Has Control, But Amarin Will Need Patience

Sarissa Capital has taken full control of Amarin. The previous management was doing some slow but decent work, but did not get time to show results.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.